Skip to main content
Delfa

Lead sponsor

Icahn School of Medicine at Mount Sinai

1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.

1

Trials led

0

Ongoing

50

Total enrollment

2

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 2
1

Trials by status

Completed
1

Trials led

TrialEligibility highlightPhaseStatusEnrollment
Riluzole in Mild Alzheimer's DiseaseMMSE 19-27Ph 2Completed50